Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study

被引:0
作者
Audrey Low
Maria A. Prats-Sedano
Elizabeth McKiernan
Stephen F. Carter
James D. Stefaniak
Stefania Nannoni
Li Su
Maria-Eleni Dounavi
Graciela Muniz-Terrera
Karen Ritchie
Brian Lawlor
Lorina Naci
Paresh Malhotra
Clare Mackay
Ivan Koychev
Craig W. Ritchie
Hugh S. Markus
John T. O’Brien
机构
[1] University of Cambridge,Department of Psychiatry, School of Clinical Medicine
[2] University of Cambridge,Department of Clinical Neurosciences
[3] University of Sheffield,Department of Neuroscience
[4] University of Edinburgh,Centre for Dementia Prevention
[5] INSERM,Institute of Neuroscience, Trinity College Dublin
[6] University of Dublin,Division of Brain Science
[7] Imperial College Healthcare NHS Trust,Department of Psychiatry
[8] Oxford University,undefined
[9] Cambridgeshire and Peterborough NHS Foundation Trust,undefined
来源
Alzheimer's Research & Therapy | / 14卷
关键词
Alzheimer’s disease; Cerebral small vessel disease; Modifiable risk factors; APOE4; Lifestyle; Prevention;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 219 条
[1]  
Pantoni L(2010)Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges Lancet Neurol 9 689-701
[2]  
Attems J(2014)The overlap between vascular disease and Alzheimer’s disease - lessons from pathology BMC Med. 12 1-12
[3]  
Jellinger KA(2016)White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network Ann Neurol. 79 929-939
[4]  
Lee S(2021)Cerebral small vessel disease in sporadic and familial Alzheimer disease Am J Pathol 191 1888-1905
[5]  
Viqar F(2014)Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort J Alzheimer’s Dis. 38 201-209
[6]  
Zimmerman ME(2020)Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study Aging (Albany NY). 12 2005-2017
[7]  
Narkhede A(2011)Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline Neurology. 77 461-468
[8]  
Tosto G(2018)A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: An invited review Am J Physiol Hear Circ Physiol. 314 H1117-H1136
[9]  
Benzinger TLS(2016)Vascular risk factors and progression of white matter hyperintensities in the Lothian Birth Cohort 1936 Neurobiol Aging. 42 116-123
[10]  
Kalaria RN(1996)Apolipoprotein E and Alzheimer’s disease Annu Rev Neurosci. 19 53-77